Year |
Citation |
Score |
2024 |
Vernaza A, Cardus DF, Smith JL, Partridge V, Baker AL, Lewis EG, Zhang A, Zhao Z, Du L. Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. Journal of Cancer. 15: 1153-1168. PMID 38356706 DOI: 10.7150/jca.89660 |
0.307 |
|
2023 |
Mesa-Diaz N, Smith MT, Cardus DF, Du L. Development of Shortened miR-506-3p Mimics Exhibiting Strong Differentiation-Inducing Activity in Neuroblastoma Cells. Molecules (Basel, Switzerland). 28. PMID 37687123 DOI: 10.3390/molecules28176295 |
0.336 |
|
2020 |
Zhao Z, Shelton SD, Oviedo A, Baker AL, Bryant CP, Omidvarnia S, Du L. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression. Journal of Experimental & Clinical Cancer Research : Cr. 39: 41. PMID 32087738 DOI: 10.1186/S13046-020-1531-2 |
0.452 |
|
2020 |
Baker AL, Zhao Z, Du L. Investigation of the Oncogenic Role of the Cell Cycle Regulator SAPCD2 in Pediatric Neuroblastoma The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.09263 |
0.314 |
|
2019 |
Kosti A, Du L, Shivram H, Qiao M, Burns S, Garcia JG, Pertsemlidis A, Iyer VR, Kokovay E, Penalva LOF. ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state. Molecular Cancer Research : McR. PMID 31624087 DOI: 10.1158/1541-7786.Mcr-19-0187 |
0.452 |
|
2018 |
Zhao Z, Partridge V, Sousares M, Shelton SD, Holland CL, Pertsemlidis A, Du L. microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi. Plos One. 13: e0208777. PMID 30550571 DOI: 10.1371/Journal.Pone.0208777 |
0.448 |
|
2018 |
Du L, Zhao Z, Suraokar M, Shelton SS, Ma X, Hsiao TH, Minna JD, Wistuba I, Pertsemlidis A. LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer. Oncotarget. 9: 29601-29618. PMID 30038707 DOI: 10.18632/Oncotarget.25642 |
0.406 |
|
2018 |
Yu X, Zhang Y, Cavazos D, Ma X, Zhao Z, Du L, Pertsemlidis A. miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer. Cell Death & Disease. 9: 193. PMID 29416000 DOI: 10.1038/S41419-017-0219-9 |
0.479 |
|
2017 |
Sousares M, Partridge V, Weigum S, Du L. MicroRNAs in neuroblastoma differentiation and differentiation therapy Advances in Modern Oncology Research. 3. DOI: 10.18282/AMOR.V3.I5.233 |
0.31 |
|
2017 |
Yu X, Ma X, Zhang Y, Zhao Z, Du L, Pertsemlidis A. Abstract 5444: Therapeutic potential of miR-195 in non-small cell lung cancer Cancer Research. 77: 5444-5444. DOI: 10.1158/1538-7445.Am2017-5444 |
0.456 |
|
2016 |
Zhao Z, Ma X, Shelton SD, Sung DC, Li M, Hernandez D, Zhang M, Losiewiz MD, Chen Y, Pertsemlidis A, Yu X, Liu Y, Du L. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells. Oncotarget. PMID 27764804 DOI: 10.18632/Oncotarget.12676 |
0.46 |
|
2016 |
Ma X, Yu X, Patolia H, Zhao Z, Du L, Pertsemlidis A. Abstract 1940: Non-coding RNA regulation of eribulin response in neuroblastoma Cancer Research. 76: 1940-1940. DOI: 10.1158/1538-7445.Am2016-1940 |
0.382 |
|
2016 |
Yu X, Zhao Z, Ma X, Du L, Pertsemlidis A. Abstract 1063: miR-195 represses the tumorigenesis of non-small cell lung cancer and synergizes with microtubule targeting agents Cancer Research. 76: 1063-1063. DOI: 10.1158/1538-7445.Am2016-1063 |
0.448 |
|
2015 |
Zhao Z, Ma X, Sung D, Li M, Kosti A, Lin G, Chen Y, Pertsemlidis A, Hsiao TH, Du L. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest. Rna Biology. 12: 538-54. PMID 25760387 DOI: 10.1080/15476286.2015.1023495 |
0.425 |
|
2015 |
Borkowski R, Du L, Zhao Z, McMillan E, Kosti A, Yang CR, Suraokar M, Wistuba II, Gazdar AF, Minna JD, White MA, Pertsemlidis A. Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling. Cancer Research. 75: 666-75. PMID 25519225 DOI: 10.1158/0008-5472.Can-14-1329 |
0.492 |
|
2014 |
Zhao Z, Ma X, Hsiao TH, Lin G, Kosti A, Yu X, Suresh U, Chen Y, Tomlinson GE, Pertsemlidis A, Du L. A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation. Oncotarget. 5: 2499-512. PMID 24811707 DOI: 10.18632/Oncotarget.1703 |
0.425 |
|
2014 |
Du L, Zhao Z, Ma X, Hsiao TH, Chen Y, Young E, Suraokar M, Wistuba I, Minna JD, Pertsemlidis A. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Oncogene. 33: 4307-15. PMID 24037530 DOI: 10.1038/Onc.2013.381 |
0.495 |
|
2014 |
Zhao Z, Ma X, Yu X, Hsiao T, Chen Y, Suraokar M, Wistuba I, Minna JD, Pertsemlidis A, Du L. Abstract 466: LMO1 is a novel oncogene in neuroendocrine lung cancer Cancer Research. 74: 466-466. DOI: 10.1158/1538-7445.Am2014-466 |
0.391 |
|
2014 |
Yu X, Zhao Z, Ma X, Du L, Pertsemlidis A. Abstract 3545: A high-throughput screen identifies microRNAs regulating lung cancer cell survival and response to paclitaxel Cancer Research. 74: 3545-3545. DOI: 10.1158/1538-7445.Am2014-3545 |
0.495 |
|
2013 |
Du L, Borkowski R, Zhao Z, Ma X, Yu X, Xie XJ, Pertsemlidis A. A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel. Rna Biology. 10: 1700-13. PMID 24157646 DOI: 10.4161/Rna.26541 |
0.447 |
|
2013 |
Du L, Zhao Z, Young E, Ma X, Wistuba I, Pertsemlidis A. Abstract 3096: miR-93-directed down-regulation of Dab2 defines a novel oncogenic pathway in lung cancer. Cancer Research. 73: 3096-3096. DOI: 10.1158/1538-7445.Am2013-3096 |
0.495 |
|
2013 |
DeSevo C, Du L, Behrens C, Wistuba I, Minna J, Pertsemlidis A. Abstract 3049: miR-10a regulates PI3K signaling and paclitaxel response in NSCLC. Cancer Research. 73: 3049-3049. DOI: 10.1158/1538-7445.Am2013-3049 |
0.445 |
|
2012 |
Du L, Pertsemlidis A. microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opinion On Biological Therapy. 12: 1221-39. PMID 22731874 DOI: 10.1517/14712598.2012.697149 |
0.423 |
|
2012 |
Du L, Subauste MC, DeSevo C, Zhao Z, Baker M, Borkowski R, Schageman JJ, Greer R, Yang CR, Suraokar M, Wistuba II, Gazdar AF, Minna JD, Pertsemlidis A. miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. Plos One. 7: e39167. PMID 22723956 DOI: 10.1371/Journal.Pone.0039167 |
0.48 |
|
2012 |
Du L, DeSevo C, Robert B, Michael B, Gazdar AF, Minna JD, Pertsemlidis A. Abstract B7: microRNA regulation of cell viability and drug sensitivity in lung cancer Cancer Research. 72: B7-B7. DOI: 10.1158/1538-7445.Nonrna12-B7 |
0.496 |
|
2012 |
DeSevo C, Du L, Behrens C, Wistuba II, Minna J, Pertsemlidis A. Abstract A2: miR-10a regulation of PIK3CA and response to taxol in non small cell lung cancer Cancer Research. 72: A2-A2. DOI: 10.1158/1538-7445.NONRNA12-A2 |
0.302 |
|
2012 |
Du L, DeSevo C, Borkowski R, Baker M, Wistuba I, Minna J, Pertsemlidis A. Abstract 140: microRNA regulation of cell viability and drug response in cancer Cancer Research. 72: 140-140. DOI: 10.1158/1538-7445.Am2012-140 |
0.482 |
|
2011 |
Nikolic D, Calderon L, Du L, Post SR. SR-A ligand and M-CSF dynamically regulate SR-A expression and function in primary macrophages via p38 MAPK activation. Bmc Immunology. 12: 37. PMID 21736734 DOI: 10.1186/1471-2172-12-37 |
0.604 |
|
2011 |
Du L, Pertsemlidis A. Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation. Journal of Molecular Cell Biology. 3: 176-80. PMID 21278200 DOI: 10.1093/Jmcb/Mjq058 |
0.328 |
|
2011 |
Du L, Subauste MC, Baker M, DeSevo C, Borkowski R, Zhong S, Schageman JJ, Greer R, Yang C, Girard L, Gazdar AF, Wistuba II, Minna JD, Pertsemlidis A. Abstract 4709: miR-337-3p and its targets STAT3 and RAP1A modulate paclitaxel sensitivity in non-small cell lung cancers (NSCLCs) Cellular and Molecular Biology. 71: 4709-4709. DOI: 10.1158/1538-7445.Am2011-4709 |
0.455 |
|
2011 |
Borkowski R, Du L, Minna JD, Gazdar AF, Pertsemlidis A. Abstract 3958: A miRNA inhibitor screen for synthetic lethal interactions in KRAS-driven NSCLC Cancer Research. 71: 3958-3958. DOI: 10.1158/1538-7445.Am2011-3958 |
0.397 |
|
2010 |
Du L, Schageman JJ, Irnov, Girard L, Hammond SM, Minna JD, Gazdar AF, Pertsemlidis A. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs. Journal of Experimental & Clinical Cancer Research : Cr. 29: 75. PMID 20624269 DOI: 10.1186/1756-9966-29-75 |
0.421 |
|
2010 |
Du L, Pertsemlidis A. microRNAs and lung cancer: tumors and 22-mers. Cancer Metastasis Reviews. 29: 109-22. PMID 20130964 DOI: 10.1007/S10555-010-9204-9 |
0.384 |
|
2010 |
Subauste MC, Sansom OJ, Porecha N, Raich N, Du L, Maher JF. Fem1b, a proapoptotic protein, mediates proteasome inhibitor-induced apoptosis of human colon cancer cells. Molecular Carcinogenesis. 49: 105-13. PMID 19908242 DOI: 10.1002/Mc.20594 |
0.361 |
|
2010 |
Du L, Pertsemlidis A. Erratum to: microRNAs and lung cancer: tumors and 22-mers Cancer and Metastasis Reviews. 29: 801-802. DOI: 10.1007/S10555-010-9230-7 |
0.371 |
|
2009 |
Subauste MC, Ventura-Holman T, Du L, Subauste JS, Chan SL, Yu VC, Maher JF. RACK1 downregulates levels of the pro-apoptotic protein Fem1b in apoptosis-resistant colon cancer cells. Cancer Biology & Therapy. 8: 2297-305. PMID 19855191 DOI: 10.4161/Cbt.8.23.10262 |
0.369 |
|
2009 |
Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A, Kurie JM. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes & Development. 23: 2140-51. PMID 19759262 DOI: 10.1101/Gad.1820209 |
0.434 |
|
2009 |
Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, Pertsemlidis A. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Molecular Cancer Research : McR. 7: 1234-43. PMID 19671678 DOI: 10.1158/1541-7786.Mcr-08-0507 |
0.5 |
|
2004 |
Du L, Post SR. Macrophage colony-stimulating factor differentially regulates low density lipoprotein and transferrin receptors. Journal of Lipid Research. 45: 1733-40. PMID 15210846 DOI: 10.1194/Jlr.M400140-Jlr200 |
0.586 |
|
Show low-probability matches. |